This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Usv Private Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Nitin Dnyaneshwar Arote: Innovator in Pharmaceutical Chemistry
Introduction
Nitin Dnyaneshwar Arote is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work has implications for the development of new medications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Nitin Arote holds a patent for the synthesis of Dabigatran etexilate, a process that involves the preparation of this important anticoagulant or its pharmaceutically acceptable salts. The patent details the creation of novel compounds, specifically Ethyl-3-{[(2-formyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl) amino}propanoate and Ethyl-3-{[(2-dichloromethyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl)amino}propanoate. These compounds are crucial for the preparation of Dabigatran etexilate, highlighting Arote's innovative approach to drug synthesis. He has 1 patent to his name.
Career Highlights
Nitin Arote is currently associated with Usv Private Limited, a company known for its commitment to pharmaceutical innovation. His role at Usv has allowed him to work on cutting-edge research and development projects, contributing to the advancement of medical science.
Collaborations
Throughout his career, Nitin has collaborated with talented professionals, including Sachin Shivaji Patil and Rajesh Ganpat Bhopalkar. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Nitin Dnyaneshwar Arote is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact healthcare significantly. His innovative contributions, particularly in the synthesis of Dabigatran etexilate, demonstrate his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
